Skip to main content
. Author manuscript; available in PMC: 2013 Oct 28.
Published in final edited form as: N Engl J Med. 2008 Dec 3;359(25):10.1056/NEJMoa0806450. doi: 10.1056/NEJMoa0806450

Table 1.

Characteristics of Facilities Evaluated in a Facility-Based Case–Control Study.

Characteristic Facilities with at Least
One Case of
Adverse Reaction
(N = 21)
Facilities with No Case
of Adverse Reaction
(N = 23)
P Value
no. (%)
Manufacturer of heparin used
 Baxter Healthcare 21 (100.0) 1 (4.3) <0.001
 APP Pharmaceuticals 2 (9.5) 20 (87.0) <0.001
 Other 0 2 (8.7) 0.49
Manufacturer of dialysis machines used
 Gambro 16 (76.2) 7 (30.4) 0.03
 Fresenius Medical Care 9 (42.9) 13 (56.5) 0.55
 B. Braun 1 (4.8) 3 (13.0) 0.61
 Other 1 (4.8) 0 0.48
Manufacturer of dialyzers used
 Gambro 10 (47.6) 8 (34.8) 0.54
 Fresenius Medical Care 9 (42.9) 14 (60.9) 0.37
 Other 7 (33.3) 6 (26.1) 0.75
Reused dialyzers 15 (71.4) 9 (39.1) 0.04
Saline priming solution delivered to patient* 11 (52.4) 13 (56.5) 0.76
Patient census >70 patients 10 (47.6) 12 (52.2) 1.00
*

Saline solution is used to clear the tubing and dialyzer of air and residual disinfectant. In some instances, some of the priming solution that has passed through the circuit is delivered to the patient.